Praveg Ltd Proposes Capital Restructuring

Praveg Limited will hold an Extraordinary General Meeting (EGM) on August 21, 2026, to seek shareholder approval for a significant capital restructuring plan.

Key Figures:

• Loan Conversion to Equity: ₹22.93 crore
• Warrant Issue Size: ₹30.25 crore

Reader Takeaway: Debt reduction and promoter confidence signal capital optimization, while working capital needs remain a focus.

What Just Happened

Praveg Limited has detailed plans for a preferential allotment involving two key transactions. Firstly, it will issue 8,33,700 equity shares to Jhaveri Credits and Capital Limited to convert an outstanding unsecured loan of ₹22.93 crore into equity. Secondly, the company plans to issue 11,00,000 fully convertible equity warrants at ₹275.00 each to members of the promoter group, including Harsh Vishnubhai Patel and others, for a total issue size of ₹30.25 crore.

Why This Matters

This move is designed to strengthen Praveg's balance sheet by reducing debt and enhancing its net worth. The issuance of warrants to the promoter group also signifies their continued commitment and confidence in the company's future prospects. The funds raised are intended for crucial working capital requirements.

The Backstory

This capital infusion aims to provide Praveg with greater financial flexibility and improve its capital structure. Converting debt to equity helps lower interest expenses and strengthens the company's financial position. The EGM's cut-off date for voting is August 14, 2026.

What Changes Now

Upon successful approval and completion of these transactions, Praveg's debt levels are expected to decrease, and its net worth will improve. The promoter group's stake is projected to increase from 46.17% to 49.87% post-warrant conversion, with public shareholding adjusting to 50.13% on a fully diluted basis.

Use of Funds

The ₹30.25 crore raised from the warrant issue will be utilized for working capital needs. This includes funding essential operational expenses such as employee salaries, raw material procurement, logistics, rent, insurance, and other statutory costs.

Risks to Watch

Investors should monitor the successful completion of the EGM approvals and the timely allotment of shares and warrants. The effective utilization of the raised funds for working capital will be crucial for maintaining operational stability and achieving growth objectives.